CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 102 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -99.5% | 13,631 | +0.7% | 0.00% | – |
| Q2 2022 | $40,000 | -68.0% | 13,535 | -66.4% | 0.00% | -100.0% |
| Q1 2022 | $125,000 | +4.2% | 40,225 | +13.3% | 0.00% | +100.0% |
| Q4 2021 | $120,000 | -4.0% | 35,495 | +23.6% | 0.00% | 0.0% |
| Q2 2021 | $125,000 | +54.3% | 28,719 | +61.9% | 0.00% | 0.0% |
| Q1 2021 | $81,000 | -44.1% | 17,739 | -11.2% | 0.00% | -66.7% |
| Q3 2020 | $145,000 | -54.8% | 19,971 | -78.3% | 0.00% | -62.5% |
| Q2 2020 | $321,000 | +146.9% | 91,992 | +407.1% | 0.01% | +60.0% |
| Q2 2019 | $130,000 | -81.9% | 18,142 | -66.4% | 0.01% | -90.6% |
| Q1 2019 | $717,000 | – | 54,003 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |